| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.2 | 7e-07 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.49 | 0.0006 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0009 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |